B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: Association with fludarabine and anti-thymocyte globulin containing conditioning regimen

Transplantation Proceedings

Volumn 35, Issue 8, 2003, Pages 3093-3095

  Lange, A ^a,b   Klimczak, A ^a   Dlubek, D ^a   Dybko, J ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b Lower Silesian Centre for Cellular Transplantation   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD38 ANTIGEN; FLUDARABINE; SYNDECAN 1; THYMOCYTE ANTIBODY;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTHRALGIA; ARTICLE; B CELL LYMPHOPROLIFERATIVE SYNDROME; B LYMPHOCYTE; BLOOD; CELL ACTIVITY; CELL ASSAY; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FEVER; HEMOLYTIC ANEMIA; HEPATITIS; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE HYPERPLASIA; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0346500856     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.10.043     Document Type: Article

References (5)

1. Deeg H.J., Socie G. Malignancies after hematopoietic stem cell transplantation many questions, some answers . Blood. 91:1998;1833.
2. Curtis R.E., Travis L.B., Rowlings P.A., et al. Risk of lymphoproliferative disorders after bone marrow transplantation a multi-institutional study . Blood. 94:1999;2208.
3. Van Esser J.W.J., van der Holt B., Meijer E., et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood. 98:2001;972.
4. Orazi A., Hromas R.A., Neiman R.S., et al. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol. 107:1997;419.
5. Gratama J.W. Epstein-Barr virus infections in bone marrow transplantation recipients. Forman S.J., Blume K.G., Thomas E.D. Bone Marrow Transplantation. 1994;429 Blackwell Scientific, Boston.